Alligent Biopharm Consulting is Consulting Services (B2B) in United States that focus on delivers integrated business. Founded in 2010. They cover business area such as Provider, medical affair agency service, aligned medical communication service, clinical trial design, datum exploration, trial management, publication strategy, TL strategy, slide development, training, specialize, KOL strategy, medical content development, strategic meeting.
2010
( 14 years old in 2024 )
Delivers Integrated
-
331 Elm Street
Long Hill, NJ 07980
United States
Private
Providermedical affair agency servicealigned medical communication serviceclinical trial designdatum explorationtrial managementpublication strategyTL strategyslide developmenttrainingspecializeKOL strategymedical content developmentstrategic meeting
* We use standard office opening hours in near Alligent Biopharm Consulting's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alligent Biopharm Consulting is Consulting Services (B2B) business from United States that founded in 2010 (14 years old in 2024), Alligent Biopharm Consulting business is focusing on Delivers Integrated.
Alligent Biopharm Consulting headquarter office and corporate office address is located in 331 Elm Street Long Hill, NJ 07980 United States.
Alligent Biopharm Consulting was founded in United States.
In 2024, Alligent Biopharm Consulting is currently focus on delivers integrated sector.
Above is snippet of Google Trends for "delivers integrated" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alligent Biopharm Consulting, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
